Stat One, LLC offers due diligence consulting services to assist companies and investment firms with their evaluation and planning.
- Investment Selection Evaluation
- Product Review
- Presentation Review
At Stat One, we know that a good strategy for a drug or device company requires a realistic assessment of the regulatory path and study assumptions. A failure to do this can sometimes lead to incorrect assumptions about the investment needs or to “rescue work” involving attempts to make up for studies headed down the wrong path.
